ProQR Therapeutics NV (MEX:PRQRN) Total Liabilities: MXN1,280.8 Mil (As of Mar. 2026)


MEX:PRQRN ProQR Therapeutics NV MEX:PRQRN
44 GF Score
Price MXN36.00
GF Value MXN40.07
! 5 Warning Signs
View Full Analysis

What is ProQR Therapeutics NV Total Liabilities?

ProQR Therapeutics NV MEX:PRQRN 44 Total Liabilities is MXN1,280.8 Mil as of Mar. 2026. GuruFocus rates MEX:PRQRN with a GF Score™ of 44/100 and a GF Value™ of MXN40.07. The stock has 5 warning signs investors should review.

ProQR Therapeutics NV's Total Liabilities for the quarter that ended in Mar. 2026 was MXN1,280.8 Mil.

ProQR Therapeutics NV's quarterly Total Liabilities declined from Sep. 2025 (MXN1,448.55 Mil) to Dec. 2025 (MXN1,336.34 Mil) and declined from Dec. 2025 (MXN1,336.34 Mil) to Mar. 2026 (MXN1,280.76 Mil).

ProQR Therapeutics NV's annual Total Liabilities declined from Dec. 2023 (MXN1,786.15 Mil) to Dec. 2024 (MXN1,733.93 Mil) and declined from Dec. 2024 (MXN1,733.93 Mil) to Dec. 2025 (MXN1,336.34 Mil).

ProQR Therapeutics NV Total Liabilities Historical Data

* Premium members only.

The historical data trend for ProQR Therapeutics NV's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProQR Therapeutics NV Total Liabilities Chart

ProQR Therapeutics NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,233.36 2,161.08 1,786.15 1,733.93 1,336.34

ProQR Therapeutics NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,609.10 1,532.27 1,448.55 1,336.34 1,280.76
MEX:PRQRN
44GF Score
ProQR Therapeutics NV MEX:PRQRN
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ProQR Therapeutics NV Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ProQR Therapeutics NV's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=683.985+(201.289+-0.00099999999991951
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+451.07+0+0)
=1,336.3

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=2377.343-1040.999
=1,336.3

ProQR Therapeutics NV's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=730.856+(189.104+-0.0010000000000332
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+360.8+0+0)
=1,280.8

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=2064.567-783.807
=1,280.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of MXN1,280.8 Mil mean?
ProQR Therapeutics NV (MEX:PRQRN) has a Total Liabilities of MXN1,280.8 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ProQR Therapeutics NV and its competitors.
Is ProQR Therapeutics NV's Total Liabilities too high?
ProQR Therapeutics NV's current Total Liabilities is MXN1,280.8 Mil. Overall, ProQR Therapeutics NV has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does ProQR Therapeutics NV's Total Liabilities compare to GALT and HRTX?
ProQR Therapeutics NV's Total Liabilities of MXN1,280.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ProQR Therapeutics NV and its competitors. ProQR Therapeutics NV's current Total Liabilities is MXN1,280.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ProQR Therapeutics NV stock overvalued right now?
ProQR Therapeutics NV (MEX:PRQRN) has a current Total Liabilities of MXN1,280.8 Mil. The stock's GF Value™ is MXN40.07, compared to a current price of MXN36.00 — trading 10.2% below its estimated fair value. The current Total Liabilities is MXN1,280.8 Mil. ProQR Therapeutics NV's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For ProQR Therapeutics NV (MEX:PRQRN), the current Total Liabilities is MXN1,280.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ProQR Therapeutics NV (MEX:PRQRN) Overvalued in 2026?

Based on GuruFocus' analysis, ProQR Therapeutics NV stock appears to be undervalued. The current stock price of MXN36.00 is trading 10.2% below its estimated GF Value™ of MXN40.07.

Key valuation signals for MEX:PRQRN:

  • Total Liabilities: MXN1,280.8 Mil
  • GF Value™: MXN40.07 vs. price of MXN36.00 (10.2% below fair value)
  • GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the MEX:PRQRN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ProQR Therapeutics NV Business Description

Other Exchanges PRQR:USA0PQ:Germany
Address Zernikedreef 9, Leiden, ZH, NLD, 2333 CK
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
44GF Score

Get the complete analysis for MEX:PRQRN

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN36.00
Price
MXN40.07
GF Value